New use for old gout treatment

An old, off-patent gout drug dramatically reduces cardiovascular event rates in patients with stable coronary artery disease, an Australian study finds.

A randomised trial found daily low-dose colchicine reduced the incidence of acute coronary syndrome, cardiac arrest and ischaemic stroke by two-thirds, compared with patients not given the drug.

Eleven patients would need to be treated to prevent one cardiovascular event, according to the study conducted in Perth private practice.

Lead author Dr